Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project.

[1]  Harlan M. Krumholz,et al.  Improving the Quality of Care for Medicare Patients with Acute Myocardial Infarction: Results from the Cooperative Cardiovascular Project , 1999 .

[2]  S. Gottlieb,et al.  Effect of Beta-Blockade on Mortality Among High-Risk and Low-Risk Patients After Myocardial Infarction , 1999 .

[3]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[4]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[5]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[6]  W. Ray,et al.  Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas , 1998 .

[7]  W. Ray,et al.  Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, Archives of internal medicine.

[8]  W. Ray,et al.  Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, JAMA.

[9]  L. Rydén,et al.  Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. , 1997, Cardiovascular research.

[10]  J. Chesebro,et al.  Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.

[11]  J. Mccormack,et al.  Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions , 1997 .

[12]  R. Califf,et al.  Outcome of acute myocardial infarction according to the specialty of the admitting physician. , 1996, The New England journal of medicine.

[13]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[14]  U. Goldbourt,et al.  Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, The American journal of cardiology.

[15]  J. Kjekshus,et al.  -Blockers and Sudden Cardiac Death , 1995, Annals of Internal Medicine.

[16]  H. Krumholz,et al.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.

[17]  E. Gilpin,et al.  Diabetic patients and beta-blockers after acute myocardial infarction. , 1990, European heart journal.

[18]  L. Rydén,et al.  Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. , 1989, European heart journal.

[19]  M. Houston.  Adverse effects of antihypertensive drug therapy on glucose intolerance. , 1986, Cardiology clinics.

[20]  J. Horn,et al.  β-Blockers and Glucose Control , 1985, Drug intelligence & clinical pharmacy.

[21]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[22]  J. Kjekshus,et al.  Timolol Treatment After Myocardial Infarction in Diabetic Patients , 1983, Diabetes Care.

[23]  M. Kendall,et al.  Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions. , 1983, Pharmacology & therapeutics.

[24]  J. Day,et al.  Adrenergic mechanisms in control of plasma lipid concentrations. , 1982, British medical journal.

[25]  P. Watkins,et al.  Can insulin-treated diabetics be given beta-adrenergic blocking drugs? , 1980, British medical journal.

[26]  D. Barnett,et al.  Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. , 1977, British medical journal.

[27]  L. Opie.  Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. , 1975, The American journal of cardiology.

[28]  S. Podolsky,et al.  Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. , 1973, Metabolism: Clinical and Experimental.